Santen Pharmaceutical Co. Ltd.
SNPHY | OTC
$11.82
$0.00 (0.00%)
Nov 2, 2026, 11:22 AM ET · Market open
Fiscal Year Period Ending | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|
PE Ratio | 15.66 | 13.64 | 19.56 | -29.27 | 18.03 | 65.36 |
PEG Ratio | 1.62 | 0.32 | -0.07 | 0.19 | 0.09 | -1.08 |
PS Ratio | 2.01 | 1.65 | 1.73 | 1.57 | 1.84 | 2.44 |
PB Ratio | 1.97 | 1.73 | 1.70 | 1.49 | 1.45 | 1.96 |
P/FCF Ratio | 15.96 | 9.11 | 8.23 | 22.03 | 17.09 | 17.55 |
P/OCF Ratio | 13.45 | 8.11 | 7.17 | 11.79 | 10.65 | 15.68 |
OCF/S Ratio | 14.92 | 20.31 | 24.06 | 13.31 | 17.29 | 15.55 |
Debt / Equity Ratio | 0.12 | 0.12 | 0.11 | 0.12 | 0.07 | 0.03 |
Quick Ratio | 1.87 | 1.99 | 2.08 | 1.94 | 2.01 | 2.10 |
Current Ratio | 2.60 | 2.58 | 2.54 | 2.38 | 2.39 | 2.63 |
Asset Turnover | 0.69 | 0.73 | 0.69 | 0.66 | 0.58 | 0.62 |
Interest Coverage | 22.68 | 51.92 | 62.46 | 65.87 | 143.90 | 215.51 |
Return on Equity | 12.58% | 12.67% | 8.71% | -5.08% | 8.06% | 3% |
Return on Assets | 8.83% | 8.86% | 6.12% | -3.55% | 5.92% | 2.30% |
Return on Invested Capital | 10.57% | 13.05% | 13.42% | 9.57% | 7.48% | 8.78% |
Dividend Yield | 2.16% | 2.45% | 2.28% | 2.88% | 2.45% | 1.84% |
Payout Ratio | 33.83% | 33.40% | 44.59% | -84.34% | 44.07% | 120.16% |
FCF Payout Ratio | 34.49% | 22.32% | 18.76% | 63.45% | 41.79% | 32.27% |
Gross Profit Margin | 55.20% | 54.40% | 54.27% | 56.11% | 55.15% | 56.38% |
Net Profit Margin | 12.81% | 12.09% | 8.82% | -5.36% | 10.22% | 3.73% |
Pretax Profit Margin | 16.27% | 15.83% | 9.89% | -2.08% | 13.38% | 4.68% |
Operating Profit Margin | 15.50% | 18.74% | 17.19% | 11.47% | 13.51% | 14.85% |
FCF Margin | 12.57% | 18.09% | 20.97% | 7.12% | 10.78% | 13.89% |
EBITDA Margin | 23.25% | 22.17% | 16.19% | 4.28% | 19.88% | 22.03% |
Add to Watchlist
Select watchlists to add or remove SNPHY